News: The Norwegian Medicines Agency has assessed 13 deaths that may have been related to the coronary vaccine. Common to those who died is that they were old and frail.
More than 25,000 Norwegians have been vaccinated with the first dose of the coronary vaccine from Pfizer and Biontech since Christmas. On Friday, the first dose of the new Moderna vaccine will be given.
So far, the Norwegian Medicines Agency has assessed 29 adverse reaction reports after the covid-19 vaccination. 13 of these had a fatal outcome, shows a new report from the Norwegian Medicines Agency.
A total of 23 deaths have been reported in connection with vaccination, but so far only 13 of these have been assessed. The other deaths are under treatment. Common side effects may have contributed to a serious course in frail elderly people, the Norwegian Medicines Agency reports.
Changes vaccine advice
All the deaths have occurred in frail, old patients in nursing homes. All are over 80 years old and some of them over 90, according to NRK.
– The reports may indicate that common side effects from mRNA vaccines, such as fever and nausea, may have led to deaths in some frail patients, says chief physician Sigurd Hortemo in the Norwegian Medicines Agency.
As a result, both the National Institute of Public Health and the Norwegian Medicines Agency have changed the coronary vaccination guide with new advice for this group.
– If you are very frail, you should probably not be vaccinated, said subject director Steinar Madsen in the Norwegian Medicines Agency at a webinar on coronary vaccine for journalists on Thursday.
He emphasizes over NRK that these cases are rare, and that many thousands of frail people have been vaccinated without a fatal outcome.
This is in line with the recommendations that came from FHI earlier this week.
As of 14 January, a total of 29 adverse reaction reports have been assessed after covid-19 vaccination. Of these, 21 are women and eight are men.
14 of these were in the age group 80–89 years, and seven were over 90 years old. Four were aged 70-79 years and four were aged 18-69 years.
13 of the reported reports had a fatal outcome, 9 had serious side effects and 7 are described as not serious side effects.
The most commonly reported adverse reactions are general symptoms, such as decreased general fever and general malaise, and injection site reactions. Gastrointestinal symptoms such as diarrhea, nausea and vomiting, and respiratory symptoms such as shortness of breath and cough are also among the most commonly reported side effects.
This is the first report on side effects from the Norwegian Medicines Agency, which will in future come with weekly side effect reports.